Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines

被引:7
作者
Bazhin, AV
Savchenko, MS
Belousov, EV
Jaques, G
Philippov, PP [1 ]
机构
[1] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Lab Biomed, Dept Cell Signalling, Moscow 119992, Russia
[2] Russian Acad Med Sci, Inst Poliomyelitis, Moscow 142782, Russia
[3] Klin Hamatol Onkol & Immunol, D-35033 Marburg, Germany
基金
俄罗斯基础研究基金会;
关键词
recoverin; paraneoplastic antigen; aberrant expression; small cell lung cancer;
D O I
10.1016/j.lungcan.2004.02.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recoverin, a retina-specific Ca2+-binding protein, is one of the paraneoplastic antigens (PNAs) which are normally present in neurons, but can also be aberrantly expressed in malignant tumors localized outside the nervous system. In this study, we have analyzed 16 small cell lung carcinoma (SCLC) and 12 non-small cell lung carcinoma cell lines and found that none of them is capable of expressing recoverin in vitro. However, two small cell lung carcinoma lines, NCI-H69 and NCI-H82, became recoverin-positive after cultivation in the presence of butyrate. Recoverin expression in the butyrate-treated cells has been detected by immunoblotting with polyclonal (monospecific) antibodies against recoverin and confirmed by the analysis of recoverin mRNA expression. To our knowledge, this work is the first to demonstrate stimulation of the aberrant expression of recoverin in cancer cell lines in vitro. This result opens the way to investigation of the mechanisms underlying the aberrant expression of recoverin, as well as other paraneoplastic antigens, in tumor cells. © 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 32 条
[1]   Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors [J].
Bazhin, AV ;
Savchenko, MS ;
Shifrina, ON ;
Demoura, SA ;
Chikina, SY ;
Jaques, G ;
Kogan, EA ;
Chuchalin, AG ;
Philippov, PP .
LUNG CANCER, 2004, 44 (02) :193-198
[2]   Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation [J].
Benjamin, D ;
Jost, JP .
NUCLEIC ACIDS RESEARCH, 2001, 29 (17) :3603-3610
[3]   DETECTION OF THE ANTI-HU ANTIBODY IN THE SERUM OF PATIENTS WITH SMALL-CELL LUNG-CANCER - A QUANTITATIVE WESTERN-BLOT-ANALYSIS [J].
DALMAU, J ;
FURNEAUX, HM ;
GRALLA, RJ ;
KRIS, MG ;
POSNER, JB .
ANNALS OF NEUROLOGY, 1990, 27 (05) :544-552
[4]  
DALMAU J, 1992, AM J PATHOL, V141, P881
[5]   RECOVERIN - A CALCIUM SENSITIVE ACTIVATOR OF RETINAL ROD GUANYLATE-CYCLASE [J].
DIZHOOR, AM ;
RAY, S ;
KUMAR, S ;
NIEMI, G ;
SPENCER, M ;
BROLLEY, D ;
WALSH, KA ;
PHILIPOV, PP ;
HURLEY, JB ;
STRYER, L .
SCIENCE, 1991, 251 (4996) :915-918
[6]  
DIZHUR A M, 1991, Biokhimiya, V56, P225
[7]   Remote neurologic manifestations of cancer [J].
Dropcho, EJ .
NEUROLOGIC CLINICS, 2002, 20 (01) :85-+
[8]  
GAZDAR AF, 1980, CANCER RES, V40, P2507
[9]   Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival [J].
Graus, F ;
Dalmau, J ;
Rene, R ;
Tora, M ;
Malats, N ;
Verschuuren, JJ ;
Cardenal, F ;
Vinolas, N ;
delMuro, JG ;
Vadell, C ;
Mason, WP ;
Rosell, R ;
Posner, JB ;
Real, FX .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) :2866-2872
[10]   Histone acetylation in chromatin structure and transcription [J].
Grunstein, M .
NATURE, 1997, 389 (6649) :349-352